Search results for "Germany"

showing 10 items of 1172 documents

Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transp…

2019

Abstract Chronic graft-versus-host disease (cGVHD) remains the leading cause of late morbidity and mortality. Despite the growing number of treatment options in cGVHD, evidence remains sparse. The German-Austrian-Swiss GVHD Consortium performed a survey on clinical practice in treatment of cGVHD among transplant centers in Germany, Austria, and Switzerland in 2009 and 2018 and compared the results. The survey performed in 2009 contained 20 questions on first-line treatment and related issues and 4 questions on second-line scenarios followed by a survey on all systemic and topic treatment options known and applied, with 31 of 36 transplant centers (86%) responding. The survey in 2018 repeate…

AdultMalemedicine.medical_specialtyRuxolitinibMedizinBronchiolitis obliteransGraft vs Host DiseaseDiseasechemistry.chemical_compoundPiperidinesGermanyNitrilesmedicineHumansIntensive care medicineBronchiolitis ObliteransImmunosuppressive treatmentImmunosuppression TherapyTransplantationbusiness.industryAdenineHematopoietic Stem Cell TransplantationHematologymedicine.diseaseClinical trialGraft-versus-host diseasePyrimidineschemistryIbrutinibAustriaChronic DiseasePyrazolesFemaleAllogeneic hematopoietic stem cell transplantbusinessSwitzerlandmedicine.drugBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
researchProduct

Hypochondriasis and health anxiety in the German population

2007

Epidemiologic studies on hypochondriasis are very rare and have not been included in large North American community surveys until now. In order to gain information on the prevalence as well as the socio-demographic characteristics of hypochondriasis, the following community study was carried out. Analyses are based on an assessment of 1575 subjects selected by socio-demographic representation criteria for the German community. All subjects completed the Illness Attitude Scales (IAS) and responded to several additional questions on sociodemographics and diagnostic criteria pertaining to Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) hypochondriasis. The IAS is…

AdultMalemedicine.medical_specialtySelf DisclosureAdolescentAnxietyQuality of life (healthcare)GermanySurveys and QuestionnairesEpidemiologymedicineHumansPsychiatrySocioeconomic statusApplied PsychologyAgedPublic healthSocial environmentGeneral MedicineMiddle AgedMental healthHypochondriasisQuality of LifeSelf-disclosureAnxietyFemalemedicine.symptomPsychologyClinical psychologyBritish Journal of Health Psychology
researchProduct

Pretherapeutic MRI for decision-making regarding selective neoadjuvant radiochemotherapy for rectal carcinoma: interim analysis of a multicentric pro…

2012

Purpose: To study the accuracy of different cutoffs for an involved circumferential resection margin (CRM) compared with T and N categories measured by MRI as basis for selective application of neoadjuvant radiochemotherapy (nRCT) in rectal carcinoma. Materials and Methods: In a prospective multicenter observational study involving 153 primarily operated patients, the preoperative results of MRI with pathohistological findings of resected specimens were compared. Results: For a cutoff of ≤1 mm for involvement of the CRM, the accuracy of preoperative MRI was 90.9% (139/153). The negative predictive value was 98.5% (134/136). The four participating departments did not differ significantly. Fo…

AdultMalemedicine.medical_specialtySensitivity and SpecificityDecision Support TechniquesMesorectal fasciaRisk FactorsGermanyRectal carcinomamedicinePrevalenceCutoffHumansRadiology Nuclear Medicine and imagingAgedAged 80 and overbusiness.industryRectal NeoplasmsReproducibility of ResultsChemoradiotherapy AdjuvantMiddle AgedInterim analysisPrognosisPredictive valueNeoadjuvant TherapyTreatment OutcomeCircumferential resection marginObservational studyFemaleCutoff pointRadiologybusinessJournal of magnetic resonance imaging : JMRI
researchProduct

Basal metabolic rate in narcoleptic patients.

2009

PATIENTS SUFFERING FROM NARCOLEPSY TEND TO BE OBESE.1,2 AMONG OTHER HYPOTHESES LOWER RESTING ENERGY EXPENDITURE HAS BEEN SUSPECTED to be the cause of the narcolepsy-associated obesity.3,4 The use of indirect calorimetry is a well-established noninvasive method to measure the energy expenditure (EE) and the resting (basal) metabolic rate (BMR). Chabas et al. recently published an evaluation of eating behavior and energy balance of 7 typical and 6 atypical narcoleptic patients and 9 controls using indirect calorimetry. Narcoleptic patients were found to have a lower energy expenditure (EE) than controls (n = 13, P = 0.07). Thus, it was concluded that narcolepsy associated obesity could be the…

AdultMalemedicine.medical_specialtyShort NoteLower energyBody Mass IndexBasal (phylogenetics)Physiology (medical)Internal medicineGermanymedicineHumansResting energy expenditureObesityNarcolepsyCalorimetry Indirectmedicine.diseaseObesityEndocrinologyBasal metabolic rateMetabolic rateFemaleNeurology (clinical)Basal MetabolismPsychologyEnergy MetabolismBody mass indexNarcolepsySleep
researchProduct

Depression, Anxiety and Quality of Life in Long-Term Survivors of Malignant Melanoma: A Register-Based Cohort Study

2015

Aim The purpose of the study was to determine anxiety and depression, quality of life, and their determinants in long-term survivors of malignant melanoma. Methods In a state cancer registry a cohort of survivors of malignant melanoma was contacted via the physician registered. Of 1302 contactable patients, 689 (52.2%) completed a questionnaire including the Patient Health Questionnaire with generalized anxiety (GAD-7) and depression (PHQ-9) and the EORTC Quality of Life Questionnaire (EORTC QLQ 30). Based on multiple regression analysis, predictors of quality of life and distress were identified. Comparison data were assessed in two waves of representative face-to-face household surveys of…

AdultMalemedicine.medical_specialtySkin NeoplasmsAdolescentPopulationlcsh:MedicineAnxietyCohort StudiesYoung AdultQuality of lifeGermanymedicineHumansRegistriesSurvivorslcsh:SciencePsychiatryeducationProspective cohort studyMelanomaAgedAged 80 and overeducation.field_of_studyMultidisciplinaryDepressionbusiness.industrylcsh:RMiddle AgedPatient Health QuestionnaireDistressCohortQuality of LifeAnxietylcsh:QFemaleSelf Reportmedicine.symptombusinessResearch ArticleCohort studyClinical psychologyPLOS ONE
researchProduct

Resource utilization and productivity loss in persons with spina bifida—an observational study of patients in a tertiary urology clinic in Germany.

2014

Background and purpose To investigate resource use and burden associated with spina bifida (SB) in Germany. Methods A questionnaire was used to obtain information on SB-related healthcare resource use and assistive technologies used for the last 1 and 10 years. Individuals with SB were recruited at a tertiary specialist clinic. To participate, persons with SB required the cognitive ability to respond or a caregiver to answer questions on their behalf. They could use personal medical charts or other records to answer. The analyses included assessment of frequency and extent of resource use for both time frames. Results Data on 88 persons with a diagnosis of SB were collected (44% female). Du…

AdultMalemedicine.medical_specialtyTertiary Care CentersCost of IllnessGermanyHealth caremedicineHumansSpinal DysraphismHospital daysbusiness.industrySpina bifidaHealth Servicesmedicine.diseaseSelf-Help DevicesHospitalizationNeurologyPhysical therapyUrology clinicResource useObservational studyFemaleNeurology (clinical)businessHealthcare providersResource utilizationEuropean journal of neurology
researchProduct

Improved Responses to Pegylated Interferon Alfa-2b and Ribavirin by Individualizing Treatment for 24–72 Weeks

2011

Guidelines recommend that patients with chronic hepatitis C virus (HCV) infection be treated with pegylated interferon and ribavirin for 24, 48, or 72 weeks, based on their virologic response to treatment. We investigated the effects of treating patients for individualized durations.We treated 398 treatment-naïve patients who had HCV genotype 1 infections with pegylated interferon alfa-2b and ribavirin for 24, 30, 36, 42, 48, 60, or 72 weeks (mean of 39 weeks, termed individualized therapy); the duration of therapy was determined based on baseline viral load and the time point at which HCV RNA levels became undetectable (measured at weeks 4, 6, 8, 12, 24, and 30). Results were compared with…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentGenotypeTranscription-mediated amplificationHepacivirusInterferon alpha-2Antiviral AgentsGastroenterologyVirusPolyethylene GlycolsYoung AdultLiver diseasechemistry.chemical_compoundPegylated interferonGermanyInternal medicineRibavirinHumansMedicinePrecision MedicineAgedDose-Response Relationship DrugHepatologybusiness.industryStandard treatmentRibavirinGastroenterologyInterferon-alphavirus diseasesHepatitis C ChronicMiddle Agedmedicine.diseaseRecombinant Proteinsdigestive system diseasesClinical trialTreatment OutcomechemistryImmunologyRNA ViralDrug Therapy CombinationFemalebusinessViral loadmedicine.drugGastroenterology
researchProduct

Prevalence and characterization of cardiac involvement in Hunter syndrome.

2011

To assess the prevalence of cardiovascular signs and symptoms in a large group of patients with Hunter syndrome, an X-linked metabolic disorder caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase.The Hunter Outcome Survey was established to characterize the natural history of Hunter syndrome and to assess the response to enzyme replacement therapy. Echocardiographic and electrocardiographic examination results were available for 102 patients who were enzyme replacement therapy-naïve in the Hunter Outcome Survey (median age at examination, approximately 8 years) as of Jan 23, 2009.The most common cardiovascular finding was valve disease, which was present in 63% of patients.…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentHeart DiseasesIduronate SulfataseLeft ventricular hypertrophyElectrocardiographyYoung AdultRisk FactorsInternal medicineGermanySurveys and QuestionnairesmedicinePrevalenceHumansYoung adultChildMucopolysaccharidosis IIRetrospective Studiesbusiness.industryMetabolic disorderIduronate-2-sulfataseRetrospective cohort studyHunter syndromeEnzyme replacement therapymedicine.diseaseUnited StatesSurgeryNatural historyEchocardiographyChild PreschoolPediatrics Perinatology and Child HealthbusinessFollow-Up StudiesThe Journal of pediatrics
researchProduct

Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students.

2013

STUDY OBJECTIVE: To estimate the 12-month prevalence of cognitive-enhancing drug use. DESIGN: Paper-and-pencil questionnaire that used the randomized response technique. SETTING: University in Mainz, Germany. PARTICIPANTS: A total of 2569 university students who completed the questionnaire. MEASUREMENTS AND MAIN RESULTS: An anonymous, specialized questionnaire that used the randomized response technique was distributed to students at the beginning of classes and was collected afterward. From the responses, we calculated the prevalence of students taking drugs only to improve their cognitive performance and not to treat underlying mental disorders such as attention-deficit-hyperactivity diso…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentUniversitiesSubstance-Related DisordersPoison controlSuicide preventionSurvey methodologyYoung AdultGermanySurveys and QuestionnairesInjury preventionEpidemiologymedicinePrevalenceHumansPharmacology (medical)Effects of sleep deprivation on cognitive performancePsychiatryStudentsNootropic Agentsbusiness.industryHuman factors and ergonomicsMiddle Agedmedicine.diseaseSubstance abuseFamily medicineFemalebusinessPharmacotherapy
researchProduct

Interdisciplinary treatment of diabetic foot wounds in the elderly : Low risk of amputations and mortality and good chance of being mobile with good …

2016

Aims: A major proportion of patients with diabetic foot syndrome are older than 65 years. Little is known about outcomes of these elderly patients. Methods: We analysed 245 treatment cases in an observational single-centre study for comorbidities and outcomes over a 6-month period. Results: In all, 122 patients had peripheral arterial disease which was significantly increasing with age ( n = 245, df = 1, χ2 = 23.06, p ⩽ 0.0001). Increasing age correlated positively with decreasing rate of revascularisations ( n = 122, df = 1, χ2 = 4.23, p = 0.039). In total, 23 (9.3%) patients died in the observation period. In-hospital mortality was 2.8%, percentage of major amputations 2.8%. In the invasi…

AdultMalemedicine.medical_specialtyTime FactorsArterial diseaseEndocrinology Diabetes and MetabolismObservation periodMedizin030209 endocrinology & metabolismComorbidity030204 cardiovascular system & hematologyAmputation Surgical03 medical and health sciences0302 clinical medicineQuality of lifeRisk FactorsGermanyDiabetes mellitusInternal medicineInternal MedicinemedicineHumansHospital MortalityMobility LimitationAgedRetrospective StudiesAged 80 and overPatient Care TeamWound HealingInterdisciplinary treatmentbusiness.industryEndovascular ProceduresAge FactorsRecovery of FunctionMiddle AgedLimb Salvagemedicine.diseaseDiabetic footDiabetic FootSurgeryTreatment OutcomeQuality of LifeFemaleObservational studyCardiology and Cardiovascular MedicinebusinessVascular Surgical Procedures
researchProduct